Haemonetics shares surged over 13% after CSL Limited announced plans to complete the rollout of Haemonetics' NexSys PCS plasma collection devices across all its US centers by the end of 2027. This move follows a non-exclusive supply agreement allowing CSL to use these devices and related disposables while keeping other suppliers available. The rollout aims to enhance plasma collection, which is vital for producing treatments for rare and chronic diseases. Haemonetics will update investors on the financial impact of this agreement in its November 2026 earnings call.
Haemonetics shares jumped over 13% following CSL Limited's announcement of a 2027 rollout for plasma collection devices. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 23:11 WIB: out of 128 priced US health stocks, 20 rose and 107 fell. Notable movers include RLAY at USD 16.91 (-5.79%), HIMS at USD 28.01 (-5.18%) with a typical hold time of 21 days and 100% buy order activity, and SLS at USD 10.79 (-4.60%).
Pacira BioSciences was downgraded from Buy to Hold by Needham following Viatris's announcement to acquire the company for $36.50 per share, valuing it at about $1.65 billion. The deal is expected to close by late 2026 and will enhance Viatris's portf...
Seaport Global increased Shopify's price target from $175 to $180, reflecting an 8.3% upside from the current price of $166.16. Shopify's shares have surged 80% since May, pushing its market value above $205 billion. The rally is driven by a strategi...
Tesco reported earnings per share of $0.69, beating estimates of $0.64, despite revenue falling short at $44.60 billion versus $49.60 billion expected. The UK supermarket raised its full-year adjusted operating profit forecast to £3.15-3.30 billion, ...
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
